Predictors of mortality in patients with pyogenic liver abscess

Netherlands Journal of Medicine

Volumn 66, Issue 5, 2008, Pages 196-203

  Chen, S C ^a   Tsai, S J ^a   Lee, Y T ^a   Yen, C H ^a   Huang, C C ^a   Lin, D B ^a   Wang, P H ^a   Chen, C C ^a   Lee, M C ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Fatal outcome; Prognosis; Pyogenic liver abscess; Retrospective study; Risk factors

Indexed keywords

AMINOGLYCOSIDE; CEPHALOSPORIN; GENTAMICIN; METRONIDAZOLE; NITROGEN; PENICILLIN DERIVATIVE; UREA;

ABSCESS DRAINAGE; ADULT; AGED; ANAEROBIC INFECTION; APACHE; ARTICLE; BACTERIUM ISOLATION; BILE DUCT STONE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; PERCUTANEOUS TRANSHEPATIC DRAINAGE; PROGNOSIS; PYOGENIC LIVER ABSCESS; RISK ASSESSMENT; RISK FACTOR; UREA NITROGEN BLOOD LEVEL;

ADULT; ANTI-INFECTIVE AGENTS; APACHE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH STATUS INDICATORS; HUMANS; LIVER ABSCESS, PYOGENIC; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 44649125400     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Huang CJ, Pitt HA, Lipsett PA, et al. Pyogenic hepatic abscess. Changing trends over 42 years. Ann Surg 1996;223:600-9.
2. Seeto RK, Rockey DC. Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine 1996;75:99-113.
3. Monsen AH, Green ST, Read RC, McKendrick MW. Liver abscess in adults: ten years experience in an UK centre. QJM 2002;95:797-802.
4. Ruiz-Hernandez JJ, Leon-Mazorra M, Conde-Martel A, Marchena-Gomez J, Hemmersbach-Miller M, Betancor-Leon P. Pyogenic liver abscesses: mortality-related factors. Eur J Gastroenterol Hepatol 2007;19:853-8.
5. Ochsner A, DeBakey M, Murray S. Pyogenic abscess of the liver. Am J Surg 1938;40:292-319.
6. Lee KT, Sheen PC, Chen JS, Ker CG. Pyogenic liver abscess: multivariate analysis of risk factors. World J Surg 1991;15:372-7.
7. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen FC, Tai DI. Prognostic factors for pyogenic abscess of the liver. J Am Coll Surgeons 1994;179:727-32.
8. Mischinger HJ, Hauser H, Rabl H, et al. Pyogenic liver abscess: studies of therapy and analysis of risk factors. World J Surg 1994;18:852-7.
9. Chu KM, Fan ST, Lai ECS, Lo CM, Wong J. Pyogenic liver abscess: an audit of experience over the past decade. Arch Surg 1996;131:148-52.
10. Chou FF, Sheen-Chen SM, Chen YS, Chen MC. Single and multiple pyogenic liver abscesses: clinical course, etiology, and results of treatment. World J Surg 1997;21:384-9.
11. Smoger SH, Mitchell CK, McClave SA. Pyogenic liver abscesses: a comparison of older and younger patients. Age Ageing 1998;27:443-8.
12. Alvarez Perez JA, Gonzalez JJ, Baldonedo RF, et al. Clinical course, treatment, and multivariate analysis of risk factors for pyogenic liver abscess. Am J Surg 2001;181:177-86.
13. Lee KT, Wang SR, Sheen PC. Pyogenic liver abscess: an audit of 10 years' experience and analysis of risk factors. Digest Surg 2001;18:459-66.
14. Wong WM, Wang BCY, Hui CK, et al. Pyogenic liver abscess: retrospective analysis of 80 cases over a 10-year period. J Gastroen Hepatol 2002;17:1001-7.
15. Hsieh CB, Tzao C, Yu CY, et al. APACHE II score and primary liver cancer history had risk of hospital mortality in patients with pyogenic liver abscess. Dig Liver Dis 2006;38:498-502.
16. Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 1998;26:1434-8.
17. Chen SC, Wu WY, Yeh CH, et al. Comparison of Escherichia coli and Klebsiella pneumoniae liver abscesses. Am J Med Sci 2007;334:97-105.
18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
19. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 5th ed. Approved standard M2-A5. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
20. Yang CC. Chen CY, Lin XZ, Chang TT, Shin JS, Lin CY. Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol 1993;88:1911-5.
21. Chou FF, Sheen-Chen SM, Chen YS, Lee TY. The comparison of clinical course and results of treatment between gas-forming and non-gas-forming pyogenic liver abscess. Arch Surg 1995;130:401-5.
22. Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS. Septic metastatic lesions of pyogenic liver abscess: their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 1991;151:1557-9.
23. Chang FY, Chou MY. Comparison of pyogenic liver abscesses caused by Kiebsiella pneumoniae and non-K. pneumoniae pathogens. J Formos Med Assoc 1995;94:232-7.
24. Chen SC, Lee YT, Lai KC, et al. Risk factors for developing metastatic infection from pyogenic liver abscesses. Swiss Med Wkly 2006;136:119-26.
25. Fang CT, Chuang YP, Shun CT, Chang SC, Wang JT. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 2004;199:697-705.
26. Yeh KM, Kurup A, Siu LK, et al. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J Clin Microbiol 2007;45:466-71.
27. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 2007;45:284-93.
28. Blanchette EA, Rubin SJ. Seroepidemiology of clinical isolates of Klebsiella in Connecticut. J Clin Microbiol 1980;11:474-8.
29. Smith SM, Digori JT, Eng RH. Epidemiology of Klebsiella antibiotic resistance and serotypes. J Clin Microbiol 1982;16:868-73.
30. Cryz SJ Jr, Mortimer PM, Mansfield V, Germanier R. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development. J Clin Microbiol 1986;23:687-90.
31. Jenney AW, Clements A, Farn JL, et al. Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. J Clin Microbiol 2006;44:102-7.
32. Rahimian J, Wilson T, Oram V, Holzman RS. Pyogenic liver abscess: recent trends in etiology and mortality. Clin Infect Dis 2004;39:1654-9.
33. Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol 2005;100:322-31.
34. Johannsen EC, Sifri CD, Madoff LC. Pyogenic liver abscesses. Infect Dis Clin N Am 2000;14:547-63.
35. Kasper DL. Virulence factors of anaerobic bacteria: an overview. Rev Infect Dis 1979;1:246-7.
36. Hofstad T. Pathogenicity of anaerobic gram-negative rods: possible mechanisms. Rev Infect Dis 1984;6:189-99.
37. Styrt B, Gorbach SL. Recent developments in the understanding of the pathogenesis and treatment of anaerobic infections. (First of two parts) N Engl J Med 1989;321:240-6.
38. Lea AS, Feliciano DV, Gentry LO. Intra-abdominal infections: an update. J Antimicrob Chemother 1982;9(Suppl A):107-13.
39. Sack RB, Rahman M, Yunus M, Khan EH. Antimicrobial resistance in organisms causing diarrheal disease. Clin Infect Div 1997;24(Suppl 1): S102-5.
40. World Health Organization. WHO report on infectious diseases 2000. Overcoming antimicrobial resistance. Geneva: WHO/CDS/2000.2.
41. Cohen ML. Antimicrobial resistance: prognosis for public health. Trends Microbiol 1994;2:422-5.
42. Vidaver AK. Uses of antimicrobials in plant agriculture. Clin Infect Dis 2002;34(Suppl 3):S107-10.
43. Schwarz S, Kehrenberg C, Walsh TR. Use of antimicrobial agents in veterinary medicine and food animal production. Int J Antimicrob Agents 2001;17:431-7.
44. Rubin MA, Samore MH. Antimicrobial use and resistance. Curr Infect Dis Rep 2002;4:491-7.
45. McGarock H. Unjustified antibiotic prescribing in the community: a major determinant of bacterial antimicrobial resistance. Pharmacoepidemiol Drug Saf 2002;11:407-8.
46. Smith RS. Pyogenic liver abscess in the aged. Am J Surg 1944;63:206-13.
47. Lee HL, Lee HC, Guo HR, Ko WC, Chen KW. Clinical significance and mechanism of gas formation of pyogenic liver abscess due to Klebsiella pneumoniae. J Clin Microbiol 2004;42:2783-5.
48. Lee TY, Wan YL, Tsai CC. Gas-containing liver abscess: radiological findings and clinical significance. Abdom Imaging 1994;19:47-52.
49. Yang WH, Shen NC. Gas-forming infection of the urinary tract: an investigation of fermentation as a mechanism. J Urol 1990;143:960-4.
50. Herman P, Pugliese V, Montagnini AL, et al. Pyogenic liver abscess: the role of surgical treatment. Int Surg 1997;82:98-101.
51. Attar B, Levendoglu H, Cuasay NS. CT-guided percutaneous aspiration and catheter drainage of pyogenic liver abscesses. Am J Gastroenterol 1986;81:550-5.
52. Maher JA Jr, Reynolds TB, Yellin AE. Successful medical treatment of pyogenic liver abscess. Gastroenterology 1979;77:618-22.